Pat's Desk — Deep-Dive Pitches on 4 Active Names

Prepared 2026-05-25 · Companion to anchorage_pat_deals_and_pitch.md Part B

Source. Desk-flagged list from a contact: Aramsco, Balcan Innovations, CoAdvantage, Internet Brands, ION Trading, Soliant, Spring Windows.

Of the 7, four are interview-deployable. Three are not, and you should know why.

Drop: - Balcan Innovations — BDT & MSD bilateral private credit, no syndicated paper, $200M growth capex, no distress - CoAdvantage — Aquiline + PrimePay merger June 2025 = integration story, not credit story; no public debt - Soliant Health — Vistria B2 5.7x clean to 2031; education-anchor stable; watchlist not active

On Anchorage involvement. None of these have publicly-confirmed Anchorage holdings (Rule 2019 / law firm press / 13F). Pitch all of them as questions, not claims — exactly the framing in the master prep. The point is to demonstrate that you read the live distressed market in Pat's lane, not that you've reverse-engineered his book.

1. SPRINGS WINDOW FASHIONS — the cleanest pitch

One-line thesis

Springs is the cleanest two-AHC out-of-court LME of 2024 — FOLO/second-out structure with Wachtell on one side and Davis Polk on the other — and at 11x pre-deal leverage on a housing-dependent business, it's still not fixed. The 2028 maturity wall makes 2026-2027 the workout window.

Why this name

• Mid-cap ($2-2.6B funded debt pre-LME) — Pat's sweet spot
• Two-group AHC with different counsel = documentary complexity, cooperation-agreement leverage
• Out-of-court FOLO/second-out structure = priming via consent, not via court
• 2028 maturity wall on FOLO + ABL = recoverable trade idea
• Sector exposure (US housing) makes the recovery thesis testable

Pre-Dec 2024 capital structure

EBITDA run-rate ~$44M/quarter (~$176M annual) → >11x leverage on senior secured alone. Moody's Caa1 with "unsustainable capital structure" call.

The December 19, 2024 transaction

• New-money First-Out Term Loan (FOLO) + ABL providing fresh liquidity
• Second-Out Term Loan refinanced substantially all of the existing $2B 1L TLB
• New 2L Notes issued in exchange for a portion of the $625M unsecured notes
• ABL extended from 2026 to 2028 — removed cross-default trigger
• Sponsor: Clearlake (acquired 2021 from AEA + BCI)

The advisor lineup (the tell)

The two-AHC structure is the whole story. Probably (a) FOLO/new-money lenders vs. (b) consenting TLB holders that rolled into Second-Out. The unsecured noteholders who didn't exchange = the primed class.

Anchorage angle

• No Rule 2019 (out-of-court, no PACER). No press release names Anchorage.
• The structurally most likely Anchorage position would be the FOLO/first-out — they prefer top-of-waterfall + new-money optionality (same posture as their 2026 First Brands DIP secondary buy).
• Use the J.Crew DIP-to-exit conversion analogy: the FOLO providers get priming + a TLB roll into Second-Out + extension of ABL = same playbook minus the courthouse.

Catalyst window

• 2026-2027: Housing recovery (or not) drives EBITDA trajectory
• 2028: FOLO + ABL refi
• Watch for: S&P/Moody's upgrade/downgrade actions; any disclosure of next year's revenue/EBITDA via private placement filings; Clearlake's exit timing (5-yr hold approaching)

Interview deployment

"The Springs Window Fashions December exchange is the one I keep going back to as a clean two-AHC out-of-court template — Wachtell-Houlihan on one side, Davis Polk-Perella on the other, with a FOLO/Second-Out priming structure. The question I'd love to understand is how the cooperation between the two groups got written: was it a single co-op covering both, or did each AHC have its own and they negotiated to each other? Because at 11x going in, with the unsecured paper at 58 and a Caa1 rating, the priming math on the second-out is doing all the work, and the 2L exchange ratio for the unsecureds is the only piece I'd want to stress-test against a downside housing scenario."

This question (a) shows you read the docs, (b) names the FAs and counsel correctly, (c) doesn't require you to claim Anchorage was in either group, (d) opens a thread Pat can run with.

Risks if you overclaim

• Don't say Anchorage was in either AHC — not publicly confirmed
• Don't claim leverage post-deal — wasn't disclosed
• Don't conflate FOLO/Second-Out with a J.Crew DIP — same logic, different mechanic

Sources

• Davis Polk — Springs Window Fashions capital raise
• Latham — Springs new capital infusion
• Debtwire — Springs creditors form group
• Bloomberg (Jul 2024) — creditors organize

2. INTERNET BRANDS — the live 2026 story

One-line thesis

The KKR-owned $4-5B Internet Brands TLB is the 2026 case study in sponsor coercion of AHC formation — KKR has warned lenders that organizing with restructuring advisors will cost them future primary deal allocations, and has blocked secondary loan transfers to hedge funds. Meanwhile the first-lien TLB is at ~80 on an AI-disruption narrative even as EBITDA grew 5% in Q4 2025.

Why this name

• LIVE story — Octus headline coverage in April 2026
• Sponsor-coercion playbook is exactly what cooperation agreements were designed to defeat
• AI disruption thesis priced into the loan (high 60s at worst) while financials improving = a "narrative vs. fundamentals" credit
• 2028 maturity wall on $4.67B of second-lien paper

Current capital structure (as of Sept 30, 2025)

Inversion alert: 1L at 80 vs 2L at 90 is structurally weird. Reflects the market pricing AI risk much more severely on the 2031 paper than the 2028 — i.e., near-term 2L holders see a refi path; longer-dated 1L holders see WebMD/Medscape getting structurally disintermediated by Perplexity/ChatGPT/Google AI Overviews.

Sponsor + co-investor stack

• KKR — acquired 2014, lead sponsor
• Temasek + Warburg Pincus — joined 2022 recapitalization
• Q4 2025: Revenue $695M (+8% YoY), adj. EBITDA $273M (+5% YoY)

The KKR coercion playbook (this is the headline)

1. April 2026 (9fin / Reuters): KKR denied secondary loan transfer requests from hedge funds attempting to build positions. The credit agreement gives the borrower a CUSIP transfer consent right — KKR is using it as a structural AHC suppression tool.
2. Octus 2026 reporting: KKR warned current TLB holders that retaining independent restructuring counsel (i.e., joining an AHC) would jeopardize their access to future KKR primary deal allocations across the rest of the platform.
3. No AHC has publicly organized. The lender update call hosted by RBC (arranger) is the sponsor's preferred channel — a 1-to-many narrative-management call rather than 1-to-1 cooperation-agreement negotiation.

The distress mechanic

The 1L is priced as if the WebMD/Medscape ad business is structurally impaired by AI search disintermediation. The Q4 5% EBITDA growth says the disintermediation hasn't yet hit cash flows — but if it does, the 2028 second-lien refi becomes a forced LME. KKR's incentive is to delay AHC organization until they can either (a) IPO Henry Schein One and use proceeds to delever, or (b) sell WebMD to a strategic — both options the AHC would price-discriminate against if organized.

Anchorage angle

• No public confirmation. The whole point of KKR's suppression playbook is that no AHC organizes publicly.
• But: hedge fund short interest is building per Debtwire (loan shorts via TRS / synthetics).
• If Anchorage were in this, the cooperation-agreement work would be exactly Pat-style — but the asymmetric size ($4-5B funded debt) is above ACO IX's stated $200M-$1.5B sweet spot.

Catalyst window

• 2026-2027: WebMD ad-rev trajectory vs. AI search erosion
• H2 2026: Possible Henry Schein One IPO (was filed pre-acquisition; relaunch on the table)
• 2028: Second-lien maturity wall — refi attempt or LME

Interview deployment

"The Internet Brands credit is fascinating to me as a case study in sponsor coercion — KKR is blocking secondary transfers and reportedly tying primary-allocation access to lenders not organizing with restructuring counsel. The cooperation-agreement question writes itself: this is exactly the structural problem co-ops were designed to solve, except the borrower is using the primary-market access lever, not just the indenture. I'd love your view — does that lever actually work in 2026 with this many sophisticated holders, or is it just delaying an AHC that organizes the moment the loan dips below 70?"

This (a) names the live KKR/9fin/Octus story specifically, (b) frames it as a structural question about co-op effectiveness, (c) doesn't require you to claim Anchorage is in it.

Risks if you overclaim

• Don't claim Anchorage is in — they'd publicly be the AHC if they were, and there is no AHC
• Don't speculate on the AI-disruption thesis being right or wrong — Pat will hold an opinion you can't predict
• Don't confuse Internet Brands (KKR/health/legal verticals) with First Brands Group (auto parts, in Ch11). Easy slip in conversation.

Sources

• Octus — KKR warns Internet Brands lenders
• 9fin (Apr 1 2026) — KKR denies trades in IB loans
• Debtwire — investors short IB loans on AI disruption bet
• S&P — IB $4.8B TLB launch

3. ION TRADING / ION PLATFORM — the European cross-border play

One-line thesis

ION Platform's October 2025 $10B refi consolidated three subsidiary silos at the OpCo level — but the HoldCo carries ~$3B of HPS/Goldman PIK and ION's effort to raise a €600M preferred-equity PIK to refi division-level PIK has stalled with multiple funds passing. The Italian "golden powers" trap on Cedacri prevents dividends from clearing back to HoldCo. This is a slow-motion structural-subordination workout, with no Ch11 jurisdiction.

Why this name

• Famously the most-levered private company in Europe — ~10x consolidated HoldCo leverage
• Andrea Pignataro's empire, 70%+ EBITDA margins, ~$2.3B revenue, ~$1.7B adj EBITDA
• Multi-silo Lux S.à r.l. issuer structure — exactly the kind of documentary complexity Anchorage prices well
• Italian "golden powers" regulatory veto on Cedacri dividends = unique cross-border doctrine
• October 2025 exchange offer required only 58% consent — the holdout 42% piece is a co-op test

Capital structure (pro forma October 2025 refi)

• Pro forma OpCo leverage: 5.7x (down from 6.2x pre-merger)
• Holdco-inclusive consolidated leverage: 10x (per S&P, end-2023)
• Ratings: S&P B+ / Moody's B2 stable (assigned Q4 2025)

Sponsor / control

• Andrea Pignataro — founder, CEO, 100% control. No traditional PE sponsor.
• 2024 acquisitions: Cerved (€1.35B), Prelios (€1.35B) — increased Italian perimeter exposure

The distress mechanic

Three things are happening simultaneously:

1. HoldCo PIK refi stalled. ION sought €600M preferred-equity PIK to refi division-level PIK; HPS declined to take more (concentration); other funds passed. Per Octus, "pens down" across multiple shops. Without this raise, the division-level PIK rolls at a higher rate or matures into a cash-pay wall.

2. Italian "golden powers" block. June 2024 — Italian court upheld government veto on €275M Cedacri bond. Dividends from Cedacri can't flow up. This structurally traps cash inside the Italian perimeter, accelerating the HoldCo coverage problem.

3. Failed Feb 2024 TLB repricing. ION pulled a $1.7B TLB repricing because the market refused tighter spreads on consolidated 10x leverage. Investors are price-disciplined on this credit — the October 2025 refi at par-for-par with $1.50-$2.50 per $1,000 consent fees was the workable structure, but tighter pricing remains a market-not-willing problem.

Anchorage angle

• No public confirmation. This is Lux/UK-domiciled, not Ch11 — no Rule 2019.
• Named privates: HPS Investment Partners + Goldman Sachs Private Credit as the HoldCo PIK lenders. Not Anchorage.
• Where Anchorage might be: the secondary market for ION Platform 2029/2032 notes. These were exchanged in Oct 2025 at par-for-par with consent fees; market trading data behind Bloomberg paywall. The 58%-consent exchange leaves 42% who could have held out — that's where co-op work would happen.

Catalyst window

• Q3 2026: Anniversary of Cerved/Prelios deals — integration disclosure
• 2026-2027: HoldCo PIK refi — does ION find a taker for the €600M, or does the structure crack
• 2028-2029 maturity: Some legacy notes due
• Cross-border: any Italian regulatory action on Cedacri / Prelios is a structural shock

Interview deployment

"ION is the European credit I'd most want your view on. Three things are tied together that I can't see from the outside: the stalled €600M preferred-equity PIK at HoldCo, the Cedacri dividend trap from the Italian golden-powers ruling, and the October exchange that needed only 58% consent. The piece I find genuinely puzzling is the holdout 42% — in a US Ch11 you'd see a co-op organize around them. In a Lux S.à r.l. structure with no court forum, what's the mechanism that prevents that 42% from blocking the next refi? Is it just the absence of a scheme-of-arrangement-equivalent, or is there a contractual mechanic that ties their hands?"

This question (a) names the three live tensions with specificity, (b) lands on a doctrinal cross-border question Pat will engage with, (c) doesn't require Max to claim Anchorage holds ION paper.

Risks if you overclaim

• Don't pretend you've read the new ION Platform indenture — you haven't
• Don't claim ION will file Ch11 — wrong jurisdiction; would be Lux/UK scheme/RP
• Don't conflate ION Trading (subsidiary, now merged into ION Platform) with ION Group (the empire) — Pignataro brand confusion is a tell

Sources

• Octus — ION struggling to raise preferred-equity PIK
• Bloomberg (Jan 2024) — ION's $13B private debt empire
• Bloomberg (Feb 2024) — ION Markets pulls $1.7B repricing
• Milbank — $10B+ ION Platform refi
• Bloomberg Law — ION Group 10x leverage in 2023, S&P

4. ARAMSCO — the smaller fit, but the highest Anchorage probability

One-line thesis

American Securities-owned restoration/abatement distributor with a $505M SOFR+475 TLB out to 2030. CCC+ downgrade October 2025 (from B- at the Oct 2023 LBO close — two-notch slide in 24 months). Jon-Don's overnight collapse in May 2025 = sector contagion signal; Aramsco bought their assets, which absorbs a peer's customer base but strains working capital. Smallest of the four, but the only one that sits squarely in ACO IX's $200M-$1.5B sweet spot.

Why this name

• Sub-$1B funded debt = directly in Pat's lane
• Recent rating action (CCC+ Oct 2025) = active distress event
• Sector contagion (Jon-Don) creates a discussable thesis
• 2030 TLB maturity gives runway, but a CCC+ at high-7x leverage = refi execution risk now
• American Securities is a credible sponsor (not a Cornell-style dividend recap story) = workout cooperation more likely

Capital structure

• Ratings: S&P B- at Oct 2023 LBO close → CCC+ at Oct 2025 downgrade
• Implied leverage: high-7x on sub-$100M EBITDA (no public revenue/EBITDA disclosure)

Sponsor history

The distress mechanic

• Sector: Restoration/abatement demand correlates with P&C insurance claim volume + housing/commercial construction
• 2024-2025 sector hits: Elevated P&C premiums crimped insurer-funded remediation jobs; commercial construction softness
• May 2025 Jon-Don collapse: Incline Equity-backed peer ceased operations overnight due to LBO debt service. Aramsco bought the assets. This is both a tailwind (customer pickup) and a stress signal — same end-markets, same sponsor archetype, same leverage profile.
• Oct 2025 S&P CCC+: Two-notch downgrade in 24 months. CCC+ implies S&P sees default risk in the next 12-24 months absent positive change.

Anchorage angle

• The only name on this list that fits ACO IX's $200M-$1.5B mandate.
• TLB at SOFR+475 trading sub-90 (inferred from CCC+; not publicly quoted)
• Per the trifecta query and the research, this is the highest-probability Anchorage rumor name — the size, the rating trajectory, the sponsor (American Securities is co-op-cooperative), and the sector all fit.
• No Rule 2019, no AHC press, no confirmed signal. Treat as plausible-but-unconfirmed.

Catalyst window

• 2026: Any further S&P/Moody's action (CCC+ to CCC = covenant negotiation watch)
• 2027: Possible TLB amendment/extension if EBITDA continues to slide
• Sector watch: Next Incline-Equity-collapse-style peer event would force AHC organization
• No hard maturity wall until 2030 — but at CCC+, refi execution risk is now

Interview deployment

"Aramsco is the smallest name on the list but I think the most interesting from a sector-contagion angle. The S&P move to CCC+ in October — two notches in 24 months from the American Securities LBO — combined with the Jon-Don collapse in May at a similar leverage profile, makes me think the next 12 months are about whether American Securities can run an amendment-extension or whether secured holders organize before the EBITDA gets to a covenant trigger. American Securities is generally seen as a workout-rational sponsor — do you find sponsor cooperativeness actually matters in CCC+ situations, or does it always come down to the secured group having priming optionality regardless?"

This (a) shows you read the S&P releases, (b) names the sector contagion specifically, (c) ends on a Pat-doctrine question (does sponsor type matter at CCC+) that he'll have a view on.

Risks if you overclaim

• Don't claim Anchorage is in — plausible but unconfirmed
• Don't quote a TLB trading level — none is public
• Don't claim EBITDA — none is public; high-7x leverage is inference from the CCC+ rating math

Sources

• S&P — Aramsco downgraded to CCC+
• S&P — Aramsco B- assigned at LBO
• Davis Polk — $80M Aramsco financing
• Industrial Distribution — Jon-Don ceases operation
• Cleanfax — Aramsco buys Jon-Don assets

NAMES TO DROP (and why)

Balcan Innovations — drop

• Actual sponsor: BDT Capital Partners (Nov 2019), now BDT & MSD Partners post-2023 merger with Michael Dell's family office
• NOT Yellow Wood (different consumer PE firm). NOT Belcan engineering services (separate company, Cognizant acquired Belcan for $1.3B in 2024).
• Why drop: Debt held in BDT & MSD's private credit funds (likely MSD Investment Corp BDC bilateral) — not syndicated, not traded. $200M capex expansion announced 2025-2027 = growth posture. No distress catalyst.
• If Pat raises it: "I looked at this — BDT's private credit shop holds the paper bilaterally and the company is in a $200M growth-capex cycle. I don't see a syndicated entry point. Did your contact mean Belcan? That was Cognizant's $1.3B acquisition last year and there's no distressed credit there either."

CoAdvantage — drop

• Aquiline Capital + Morgan Stanley Capital Partners (now Aquiline solo post-2023)
• Merged with PrimePay June 30, 2025 — integration story
• No public debt facility disclosures, no rating agency action
• Why drop: Performing credit, no syndicated paper, growth story not distress
• If Pat raises it: "Aquiline rolled CoAdvantage and PrimePay together last June into an integrated PEO + payroll platform. Private credit, no rated debt. I don't see a distressed angle unless your contact knows something specific about the integration."

Soliant Health — keep on watchlist, not pitch

• Vistria Group acquired July 2024 from Olympus Partners for $2.5B at 9.6x EBITDA (~$261M EBITDA, ~$1.49B funded debt, 5.7x leverage, Moody's B2)
• 80% of EBITDA is school-based therapy (IDEA-mandated SLP/OT/PT) — structurally resilient
• 20% is healthcare staffing — Moody's flagged 35-40% revenue decline in 2024 as pandemic premiums normalize
• No near-term maturity (2031 TLB), no LME, no Ch11
• Why not a pitch: Watch story, not active workout. Education anchor too stable for distress.
• If Pat raises it: "Vistria bought it at 9.6x from Olympus last July at $2.5B EV / 5.7x leverage. The school-based therapy business is the anchor — IDEA mandate makes SLP/OT/PT placement non-cyclical. The healthcare staffing tail is where Moody's flagged the 35-40% rev decline post-pandemic. Watchlist, not in a workout — would expect this to need a B3 downgrade before it's interesting."

HOW TO USE THIS DOC

Don't memorize all four for the room. Pick the one you'd volunteer if Pat asks "what live name in our lane have you been thinking about" — and have the other three ready as "follow-up question" material if he names them himself.

Recommended primary pitch: Springs Window Fashions. It's the cleanest because: - Closed deal — you can speak to the structure without speculating about Anchorage's position - Two-AHC mechanic is a Pat-doctrine question - Right size for ACO IX - No coercion overlay (unlike Internet Brands) that forces you into uncomfortable territory

Recommended secondary if Pat asks "anything else?": Internet Brands for the live KKR coercion story (with the explicit caveat that the size is above ACO IX's stated lane).

Use ION as the cross-border probe if the conversation drifts to European RX, since Pat ran Altice France steerco.

Use Aramsco only if Pat probes specifically into sub-$1B credits.

TRIFECTA CONSENSUS (4-MODEL PANEL)

Run 1 had a prompt bug (the 7 names lived in the script's docstring but not in the USER variable sent to models). Claude refused to fabricate and correctly flagged "only one of seven names was actually transmitted." Gemini and DeepSeek hallucinated entirely different names (Serta/Envision/Avaya / Joann/Saks/Neiman). OpenAI failed on schema (additionalProperties:false missing). Fixed and re-ran — full 4/4 success on Run 2.

Interview-actionability scores (1-10)

Consensus calls

• Spring Windows as primary pitch: unanimous lock
• Internet Brands as secondary: confirmed (DeepSeek's 3 is the dissent; reasoning was likely the size being above ACO IX's lane, which my doc already flags)
• Drop CoAdvantage + Balcan: confirmed by 3/4
• Aramsco / ION: legitimate split — keep as Tier 3 supplementary pitches
• Soliant: Claude promoted to top-3 citing the Vistria LBO underwriting + school-district budget exposure angle. My doc has Soliant as "watch, not pitch" — Claude's framing suggests a fuller writeup if the conversation goes long on healthcare staffing comps. Worth holding in the back pocket.

Per project memory

"Claude tends to give the most rigorous reviews in the panel."

Confirmed twice this session — Claude caught the prompt bug in Run 1, and Claude's top-3 in Run 2 included a name the simpler models dismissed because they over-weighted the absence of a confirmed Anchorage public position rather than the underlying credit setup. Take Claude's reviews seriously when the panel splits.

Raw outputs: /root/tmp/trifecta_anchorage_pat_names_2026-05-25_result.json